Global Chronic Wound Care Market Insights Forecasts to 2033

• The Global Chronic Wound Care Market Size was Valued at USD 12.54 Billion in 2023.
• The Market Size is Growing at a CAGR of 7.58% from 2023 to 2033.
• The Worldwide Chronic Wound Care Market Size is Expected to Reach USD 26.05 Billion by 2033.
• Europe is Expected to Grow the fastest during the forecast period.

The Global Chronic Wound Care Market Size is Anticipated to Exceed USD 26.05 Billion by 2033, Growing at a CAGR of 7.58% from 2023 to 2033.

Market Overview

A chronic wound is a wound that does not heal in an orderly set of stages and in a predictable amount of time. Chronic wounds are considered to be a common type of skin injury. Wounds that do not progress to healing and fail to show any signs of healing within four weeks are presumptively diagnosed as chronic wounds. These wounds often remain in the inflammatory stage for too long time and may never heal or may take years. It was estimated that around 6.7 million people in the world were suffering from chronic wounds according to various research reports and data published by Mission Regional Medical Center. Chronic wounds are treated according to the TIME principle- tissue debridement, infection control, moisture balance, and edges of the wound. Symptoms such as loss of skin or tissue surrounding the wound or the duration required for healing are being recognized for chronic wounds. The growing usage of active therapies in the treatment of chronic wounds is due to the increasing application of bioactive therapies such as bioequivalent and skin grafts in treating these wounds.

Report Coverage

This research report categorizes the market for the global chronic wound care market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global chronic wound care market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global chronic wound care market.

Driving Factors

The growing prevalence of chronic wounds surges the demand for treatment (dressings, devices, and active therapies). The increasing prevalence of different types of chronic wounds generates demand for treatment products subsequently fueling the adoption of wound dressings, devices, and other products. These factors are augmented to aid the global chronic wound care market. In addition, the growing technological advancement and R&D investment for the launching of several novel wound healing products by market players for diabetic foot ulcers and others contributed to the market expansion of chronic wound care. Furthermore, the rising obesity rate among people is likely to drive the market as obese people are at high risk of pressure ulcers. These factors are expected to boost the global chronic wound care market during the forecast period.

Restraining Factors

The expensive treatment of chronic wound care such as advanced wound dressings, chronic wound care devices, and bioactive products are restraining the market. Further, a lack of awareness about advanced wound care products leads to improper treatment that ultimately leads to impeding the market.

Market Segmentation

The global chronic wound care market share is classified into type, product, and end user.

• The diabetic ulcers segment is expected to hold the largest share of the global chronic wound care market during the forecast period.   

Based on the type, the global chronic wound care market is categorized into diabetic ulcers, pressure ulcers, venous leg ulcers, and others. Among these, the diabetic ulcers segment is expected to hold the largest share of the global chronic wound care market during the forecast period. The growing prevalence of diabetes leads to an increasing incidence of diabetic ulcers. As per the research study of the National Center for Biotechnology Info., about 5% of diabetic patients in the US develop foot ulcers and 1% of patients.

• The advanced wound dressings segment is witnessing significant CAGR growth over the forecast timeframe.   

Based on the product, the global chronic wound care market is categorized into advanced wound dressings, wound care devices, active therapy, and others. Among these, the advanced wound dressings segment is witnessing significant CAGR growth over the forecast timeframe. The availability of advanced forms of wound care products at lower cost with high efficiency is likely to grow the market in the advanced wound dressing segment. Further, the introduction of advanced devices by key market players is also responsible for increasing market growth.

• The hospitals & wound clinics segment dominates the market with the largest revenue share over the forecast period.

Based on the end user, the global chronic wound care market is categorized into hospitals & wound clinics and homecare settings & others. Among these, the hospitals & wound clinics segment dominates the market with the largest revenue share over the forecast period. Chronic wound care treatment in hospitals and wound clinics is more advantageous as it eases the treatment of hard-to-heal chronic wounds.

Regional Segment Analysis of the Global Chronic Wound Care Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global chronic wound care market over the predicted timeframe.

North America is projected to hold the largest share of the global chronic wound care market over the forecast period. North America has a robust and stable economy, and nations like the US and Canada are important players in international trade and business. The presence of numerous centers of innovation and technology, benefits draws in funding for R&D and investment, resulting in innovative goods and services that ultimately lead to propelling the market growth in the region.

Europe is expected to grow at the fastest CAGR growth of the global chronic wound care market during the forecast period. The increasing cases of chronic diseases and high expenditure on treatment of chronic wound treatment are expected to increase the market growth in the region. Further, increasing R&D investment for the introduction of novel products by key manufacturing companies for the treatment promotes the market growth in the region.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global chronic wound care market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Coloplast Corp.
• 3M Company
• Medline Industries, Inc.
• ConvaTec Group PLC
• Derma Sciences (Integra LifeSciences)
• Smith & Nephew
• B. Braun Melsungen AG
• Cardinal Health
• Tissue Regenix
• Molnlycke Health Care AB
• Ethicon (Johnson & Johnson)
• Baxter International
• Paul Hartmann AG
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In June 2023, Evonik company JeNaCell launched wound dressing epicite balance for chronic wounds. It enables superior wound cleansing and reactivates the healing of slow-healing wounds.

• In January 2023, MIMEDX announced the commercial launch of EPIFIX in Japan with an exclusive distribution agreement with GUNZE MEDICAL LIMITED. MIMEDX aligned with the leading distributor of wound care products in Japan to capitalize on the first-mover advantage for EPIFIX.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global chronic wound care market based on the below-mentioned segments: 

Global Chronic Wound Care Market, By Type

• Diabetic Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Others

Global Chronic Wound Care Market, By Product

• Advanced Wound Dressings
• Wound Care Devices
• Active Therapy
• Others

Global Chronic Wound Care Market, By End User

• Hospitals & Wound Clinics
• Homecare Settings
• Others

Global Chronic Wound Care Market, Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa